Methoxyphenamine
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C11H17NO |
Molar mass | 179.26 g/mol |
3D model (JSmol) | |
| |
|
WikiDoc Resources for Methoxyphenamine |
Articles |
---|
Most recent articles on Methoxyphenamine Most cited articles on Methoxyphenamine |
Media |
Powerpoint slides on Methoxyphenamine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Methoxyphenamine at Clinical Trials.gov Trial results on Methoxyphenamine Clinical Trials on Methoxyphenamine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Methoxyphenamine NICE Guidance on Methoxyphenamine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Methoxyphenamine Discussion groups on Methoxyphenamine Patient Handouts on Methoxyphenamine Directions to Hospitals Treating Methoxyphenamine Risk calculators and risk factors for Methoxyphenamine
|
Healthcare Provider Resources |
Causes & Risk Factors for Methoxyphenamine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Methoxyphenamine (trade names ASMI, Euspirol, Orthoxine, Ortodrinex, Proasma), also known as 2-methoxy-N-methylamphetamine (OMMA), is a β-adrenergic receptor agonist of the amphetamine class used as a bronchodilator.[1]
Chemistry
Methoxyphenamine was first synthesized at the Upjohn company by Woodruff and co-workers.[2] A later synthesis by Heinzelman, from the same company, corrects the m.p. given for methoxyphenamine hydrochloride in the earlier paper, and describes an improved synthetic procedure, as well as resolution of the racemic methoxyphenamine.[3]
References
- ↑ Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.
- ↑ E. H. Woodruff, J. P. Lambooy and W. E. Burt (1940). "Physiologically active amines. III. Secondary and tertiary β-phenylpropylamines and β-phenylisopropylamines." J. Am. Chem. Soc. 62 922-924.
- ↑ R. V. Heinzelman (1953). "Physiologically active secondary amines. β-(o-Methoxyphenyl)-isopropyl-N-methylamine and related compounds." J. Am. Chem. Soc. 75 921-925.
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles containing unverified chemical infoboxes
- Phenol ethers
- Drug